191 related articles for article (PubMed ID: 23815917)
1. [Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome].
Li J; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):657-61. PubMed ID: 23815917
[TBL] [Abstract][Full Text] [Related]
2. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
Della Porta MG; Lanza F; Del Vecchio L;
Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
[TBL] [Abstract][Full Text] [Related]
4. Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.
Xiong B; Tang ZH; Zou P; Yue QF; Chen WX; Liu XY
Acta Haematol; 2014; 131(2):126-32. PubMed ID: 24158033
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
6. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
7. [Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia].
Gu LL; Kang HY; Pan YL; Liu GX; Ge SJ; Li MY; Wang CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):138-43. PubMed ID: 26913410
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes.
Hatfill SJ; Fester ED; Steytler JG
Hematol Pathol; 1992; 6(2):87-93. PubMed ID: 1607344
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
12. [Classification and clinical findings of myelodysplastic syndromes].
Tsuruda K; Hasegawa H; Fuchigami M; Uno N; Morinaga Y; Miyazaki Y; Yanagihara K
Rinsho Byori; 2014 Apr; 62(4):359-68. PubMed ID: 25022065
[TBL] [Abstract][Full Text] [Related]
13. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
14. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
Senent L; Arenillas L; Luño E; Ruiz JC; Sanz G; Florensa L
Haematologica; 2013 Apr; 98(4):568-75. PubMed ID: 23065505
[TBL] [Abstract][Full Text] [Related]
16. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
Liu XF; Wang BM; Yi FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
[TBL] [Abstract][Full Text] [Related]
19. T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance.
Zhang X; Sokol L; Bennett JM; Moscinski LC; List A; Zhang L
Leuk Res; 2016 Apr; 43():18-23. PubMed ID: 26927701
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of morbidly hematopoietic characteristics in 69 patients with myelodysplastic syndrome].
Wu YN; Luo ZB; Wang C; Li J; Luo HY; He DY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):150-4. PubMed ID: 25687064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]